A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age

Study Title
A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age
Teva Identifier
TV46046-WH-10159
ClinicalTrials.gov Identifier
NCT04682353
Study Status
Completed
Trial Condition(s)
Contraception
Interventions
Drug: TV-46046|Drug: Depo-subQ Provera
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
female-symbol-icon

Key Participation Requirements

Gender
Female
Age group
Adult
Age Range
18 Years to 45 Years
Trial Duration
December 14, 2020 - January 12, 2023
Phase
Phase 1

Study Type

Interventional